Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, continues to support medical industry trends with the launch of a new wear resistant, high lubricity polycarbonate (PC) at two major industry shows: Pharmapack in Paris, France from February 5-6 at Booth B86, and MD&M West in Anaheim, California from February 11-13 at Booth 3259.
The global medical industry is constantly evolving to address megatrends such as a rapidly growing and aging population. This is creating a need for home healthcare and self-administered treatments as well as medical wearables and patient-friendly devices.
Trinseo’s wear resistant, high lubricity PC has been designed for drug delivery devices and surgical tools, which are growing in importance for their convenience and cost saving potential. Part of Trinseo’s CALIBRE™ Polycarbonate Resins series, the new material platform provides a solution for the low friction movement of one material over another, extending product life and minimizing noise without external lubricants.
Beside this latest innovation, Trinseo is also recognized globally for its leadership position in advanced chemical resistant materials and will showcase its EMERGE™ 9000 product portfolio as well. This product range is used extensively in diagnostic equipment housings to resist the aggressive cleansers and disinfectants used by healthcare professionals to fight healthcare associated infections (HAIs), which remain a growing concern.
“Trinseo plastics satisfy the demand for aesthetically-pleasing devices designed for human interaction,” said Aldo Zanetti, Global Market Leader Medical, Personal Care & Household, Trinseo. “At both Pharmapack and MD&M West, we look forward to sharing how Trinseo supports medical device manufacturers and also pharmaceutical companies, particularly with our latest grades for drug delivery device applications.”
With three decades of industry experience, Trinseo supports a variety of applications including drug delivery devices, surgical tools, equipment housings, and medical wearables. Its medical thermoplastic elastomers (TPE) range from soft to semi-rigid, transparent for IV drip chambers. In addition to traditional plastics, Trinseo works cross-industry to help customers achieve objectives for sustainable materials with its post-consumer recycled (PCR) content containing resins, bio-based technologies, and through creative supply chain initiatives. Trinseo holds an ISO 13485 certification for its management system applicable to the design, development, and manufacturing of polymers and polymer blends and compounds for medical applications.
Trinseo (NYSE: TSE), a specialty material solutions provider, partners with companies to bring ideas to life in an imaginative, smart, and sustainability-focused manner by combining its premier expertise, forward-looking innovations and best-in-class materials to unlock value for companies and consumers.
From design to manufacturing, Trinseo taps into decades of experience in diverse material solutions to address customers’ unique challenges in a wide range of industries, including consumer goods, mobility, building and construction, and medical.
Trinseo’s approximately 3,400 employees bring endless creativity to reimagining the possibilities with clients all over the world from the company’s locations in North America, Europe, and Asia Pacific. Trinseo reported net sales of approximately $4.8 billion in 2021. Discover more by visiting www.trinseo.com and connecting with Trinseo on LinkedIn, Twitter, Facebook and WeChat.
Cautionary Note on Forward-Looking Statements
This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, our ability to successfully execute our transformation strategy and business strategy; our ability to integrate acquired businesses; global supply chain volatility, increased costs or disruption in the supply of raw materials or increased costs for transportation of our products; the nature of investment opportunities presented to the Company from time to time; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.